Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Verstraete

Showing results (101-110 of 414) with videos related to

Pageof 42
Sort By:
La Clinica Terapeutica|June 15, 1975
[Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]M Verstraete
Acta Clinica Belgica|January 1, 1977
Thrombolytic drugs: quo vadis?M Verstraete
Drugs|September 1, 1982
Current therapy for intermittent claudicationM Verstraete
Thrombosis and Haemostasis|July 1, 1997
Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balanceM Verstraete
Verhandelingen - Koninklijke Vlaamse Academie Voor Geneeskunde Van Belgie|January 1, 1970
[Administrative and clinical evaluation of new medications]M Verstraete
Acta Cardiologica|January 1, 1985
Systemic versus intracoronary thrombolytic treatment in acute myocardial infarctionM Verstraete
Semaine Des Hopitaux. Therapeutique|September 1, 1976
[Prevention of postoperative deep vein thrombosis and pulmonary embolism by low-dose heparin injection or by dextran]M Verstraete
Surgery, Gynecology & Obstetrics|December 1, 1976
The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextranM Verstraete
Thrombosis and Haemostasis|June 30, 1978
International committee communications. Registry of prospective clinical trials. Third reportM Verstraete
Acta Cardiologica|January 1, 1972
The effect of lipids on platelets, blood coagulation and fibrinolysisM Verstraete
Pageof 42

Showing results (101-110 of 414) with videos related to

Sort By:
Pageof 42
La Clinica Terapeutica|June 15, 1975
[Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]M Verstraete
Acta Clinica Belgica|January 1, 1977
Thrombolytic drugs: quo vadis?M Verstraete
Drugs|September 1, 1982
Current therapy for intermittent claudicationM Verstraete
Thrombosis and Haemostasis|July 1, 1997
Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balanceM Verstraete
Verhandelingen - Koninklijke Vlaamse Academie Voor Geneeskunde Van Belgie|January 1, 1970
[Administrative and clinical evaluation of new medications]M Verstraete
Acta Cardiologica|January 1, 1985
Systemic versus intracoronary thrombolytic treatment in acute myocardial infarctionM Verstraete
Semaine Des Hopitaux. Therapeutique|September 1, 1976
[Prevention of postoperative deep vein thrombosis and pulmonary embolism by low-dose heparin injection or by dextran]M Verstraete
Surgery, Gynecology & Obstetrics|December 1, 1976
The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextranM Verstraete
Thrombosis and Haemostasis|June 30, 1978
International committee communications. Registry of prospective clinical trials. Third reportM Verstraete
Acta Cardiologica|January 1, 1972
The effect of lipids on platelets, blood coagulation and fibrinolysisM Verstraete
Pageof 42